VIEMED HEALTHCARE, INC. (VMD) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-01-23

Key Insights

The reporting person, Jeremy Trahan, is the General Counsel of Viemed Healthcare, Inc. and has exercised restricted stock units (RSUs) and phantom share units (PSUs) granted in 2025, indicating his ongoing commitment to the company.
Trahan has also sold a portion of the acquired shares to cover tax obligations, which is a common practice for executives receiving equity-based compensation.
The timing and amounts of the transactions suggest Trahan is managing his equity holdings in line with the company's compensation plans and his personal financial needs.

Want the newest filings?

This analysis covers the filing from 2026-01-23. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-23

The reporting person, Jerome Cambre, is the Vice President of Sales of Viemed Healthcare, Inc. and is exercising restricted stock units (RSUs) and phantom share units.
Cambre is disposing of some of the shares acquired through the RSU and phantom share unit vesting to cover tax obligations, while retaining the majority of the shares.
The timing of the RSU and phantom share unit vesting and the relatively small number of shares being sold suggest ongoing alignment between Cambre's interests and those of shareholders.

Filed: 2026-01-21

The CEO, Casey Hoyt, exercised 40,068 restricted stock units (RSUs) and 10,017 phantom share units, indicating his continued commitment to the company.
Hoyt also sold 10,017 common shares, likely to cover tax obligations related to the RSU and phantom share vesting, suggesting he is not cashing out a significant portion of his holdings.
The company granted Hoyt an additional 172,155 RSUs and 43,039 phantom share units, further aligning his interests with those of shareholders through long-term incentive compensation.

Filed: 2026-01-21

Insider Jeremy Trahan, General Counsel, has made multiple transactions involving Viemed Healthcare, Inc. (VMD) shares, including the vesting and exercise of restricted stock units and phantom share units.
Trahan has acquired a significant number of additional restricted stock units and phantom share units, totaling 62,950 shares, suggesting continued confidence in the company's future.
The reported transactions indicate Trahan's ongoing alignment with shareholders' interests through equity-based compensation, which may be viewed positively by investors.

Filed: 2026-01-21

The reporting person, Trae Fitzgerald, who is the Chief Financial Officer of Viemed Healthcare, Inc. (VMD), has acquired 9,590 common shares through the vesting of restricted stock units (RSUs) and 2,397 common shares through the vesting of phantom share units.
Fitzgerald has also disposed of 2,397 common shares, likely to cover tax obligations related to the vesting of the phantom share units.
The reporting person has been granted additional RSUs and phantom share units, totaling 46,662 and 11,666 respectively, which will vest over the next three years, indicating the company's commitment to incentivizing and retaining its CFO.

Filed: 2026-01-21

The reporting person, Jerome Cambre, who is the Vice President of Sales at Viemed Healthcare, Inc. (VMD), exercised 8,525 restricted stock units (RSUs) and 2,132 phantom share units, while also disposing of 2,132 common shares.
The reporting person also received a new grant of 40,676 RSUs and 10,169 phantom share units, which will vest over a 3-year period.
The reported transactions suggest that the reporting person is actively managing their equity-based compensation and maintaining a significant ownership stake in the company.

Filed: 2026-01-21

Insider William Todd Zehnder, the Chief Operating Officer, exercised 26,939 restricted stock units (RSUs) and 6,735 phantom share units. This indicates he is taking a long-term position in the company.
Zehnder also sold 6,735 shares, likely to cover tax obligations from the vesting of the RSUs and phantom shares. This modest sale suggests he remains bullish on the company's prospects.
The company granted Zehnder an additional 118,759 RSUs and 29,690 phantom share units, further aligning his interests with shareholders through long-term equity incentives.

Filed: 2026-01-21

The reporting person, Michael Moore, who is the President of Viemed Healthcare, Inc. (VMD), has engaged in significant insider trading activity, acquiring and disposing of a large number of common shares and derivative securities.
The insider transactions include the vesting and settlement of restricted stock units and phantom share units, as well as the withholding of shares to cover tax obligations.
The reporting person has also been granted additional restricted stock units and phantom share units, further increasing their equity stake in the company.

Filed: 2026-01-21

The reporting person, William Frazier, was granted 11,690 restricted stock units (RSUs) and 2,922 phantom share units, which vest over the next three years. This indicates potential long-term alignment between Frazier and the company's interests.
Frazier holds the position of Chief Medical Officer, suggesting he plays a key role in the company's operations and strategy.
The reported transactions occur on January 19, 2026, which is a recent date, providing timely information about insider activity.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.